Inhibition of VEGF receptors induces pituitary apoplexy: An experimental study in mice

Anti-vascular endothelial growth factor (VEGF) therapy has been developed for the treatment of a variety of cancers. Although this therapy may be a promising alternative treatment for refractory pituitary adenomas and pituitary carcinomas, the effects of anti-VEGF agents on the pituitary gland are n...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugita, Yoshito, Takada, Shigeki, Tanigaki, Kenji, Muraki, Kazue, Uemura, Munehiro, Hojo, Masato, Miyamoto, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019612/
https://www.ncbi.nlm.nih.gov/pubmed/36928058
http://dx.doi.org/10.1371/journal.pone.0279634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019612/
https://www.ncbi.nlm.nih.gov/pubmed/36928058
http://dx.doi.org/10.1371/journal.pone.0279634

Ejemplares similares